Achieve Life Sciences is trading 6.7% down at $5.97 today, following its 2026 Annual Meeting of Stockholders. During the meeting, stockholders voted on a proposal to significantly increase the number of authorized common shares from 150 million to 300 million. This proposal could provide the company with flexibility for future financing or corporate actions. The decline also appears influenced by broader market volatility and profit-taking.